v3.26.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Series 1 Preferred Stock [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Preferred [Member]
AOCI Attributable to Parent [Member]
Total
Non-controlling Interest [Member]
Balance at Sep. 30, 2024 $ 2,457 $ 50 $ 1 $ 73,262,549 $ (71,355,386) $ (148,291) $ 2,949,297 $ 4,710,677 $ 250,165
Balance, shares at Sep. 30, 2024 2,456,827 50,000 946            
Foreign currency translation loss             (131,439) (131,439)  
Dividends paid in Series 1 preferred shares $ 123     (123)        
Dividends paid in Series 1 preferred shares, shares 123,167                
Exercise of Series A warrants     $ 89 21,515,688       21,515,777  
Exercise of Series A warrants, shares     88,492            
Exercise of Series B warrants     $ 22 1,095,709       1,095,731  
Exercise of Series B warrants, shares     22,244            
Issuance of roundup shares     $ 7 (7)        
Issuance of roundup shares, shares     7,299            
Net income       (28,754,367)   (28,754,367)  
Share-based compensation       4,087       4,087  
Loss attributable to noncontrolling interest               (180,152)
Balance at Dec. 31, 2024 $ 2,580 $ 50 $ 119 95,877,903 (100,109,753) (148,291) 2,817,858 (1,559,534) 70,013
Balance, shares at Dec. 31, 2024 2,579,994 50,000 118,981            
Balance at Sep. 30, 2024 $ 2,457 $ 50 $ 1 73,262,549 (71,355,386) (148,291) 2,949,297 4,710,677 250,165
Balance, shares at Sep. 30, 2024 2,456,827 50,000 946            
Net income               (20,116,888)  
Balance at Mar. 31, 2025 $ 2,580 $ 50 $ 119 95,880,999 (91,402,261) (148,291) 2,394,376 6,727,572
Balance, shares at Mar. 31, 2025 2,579,994 50,000 118,982            
Balance at Sep. 30, 2024 $ 2,457 $ 50 $ 1 73,262,549 (71,355,386) (148,291) 2,949,297 4,710,677 250,165
Balance, shares at Sep. 30, 2024 2,456,827 50,000 946            
Net income               (28,112,368)  
Balance at Sep. 30, 2025 $ 2,705 $ 50 $ 831 105,668,565 (99,397,741) (148,291) 2,591,340 8,717,459  
Balance, shares at Sep. 30, 2025 2,705,327 50,000 830,606            
Balance at Dec. 31, 2024 $ 2,580 $ 50 $ 119 95,877,903 (100,109,753) (148,291) 2,817,858 (1,559,534) 70,013
Balance, shares at Dec. 31, 2024 2,579,994 50,000 118,981            
Foreign currency translation loss             (423,482) (423,482)  
Net income     8,637,479   8,637,479  
Share-based compensation       3,096       3,096  
Rounding shares                
Rounding shares, shares     1            
Elimination of non-controlling interest         70,013     70,013 (70,013)
Balance at Mar. 31, 2025 $ 2,580 $ 50 $ 119 95,880,999 (91,402,261) (148,291) 2,394,376 6,727,572
Balance, shares at Mar. 31, 2025 2,579,994 50,000 118,982            
Balance at Sep. 30, 2025 $ 2,705 $ 50 $ 831 105,668,565 (99,397,741) (148,291) 2,591,340 8,717,459  
Balance, shares at Sep. 30, 2025 2,705,327 50,000 830,606            
Foreign currency translation loss             (719,485) (719,485)  
Dividends paid in Series 1 preferred shares $ 136     (136)        
Dividends paid in Series 1 preferred shares, shares 135,592                
Shares issued to pay debt     $ 3,001 19,639,282       19,642,283  
Shares issued to pay debt, shares     3,000,296            
Exercise of Series A warrants     $ 30 211,068       211,098  
Exercise of Series A warrants, shares     29,943            
Exercise of Series B warrants     $ 2,317 15,802,537       15,804,854  
Exercise of Series B warrants, shares     2,316,480            
Shares issued in offering     $ 2,356 5,988,171       5,990,527  
Shares issued in offering, shares     2,355,556            
Issuance of roundup shares     $ 66 (66)        
Issuance of roundup shares, shares     67,671            
Net income       (20,556,147)   (20,556,147)  
Balance at Dec. 31, 2025 $ 2,841 $ 50 $ 8,601 147,309,421 (119,953,888) (148,291) 1,871,855 29,090,589  
Balance, shares at Dec. 31, 2025 2,840,919 50,000 8,600,552            
Balance at Sep. 30, 2025 $ 2,705 $ 50 $ 831 105,668,565 (99,397,741) (148,291) 2,591,340 8,717,459  
Balance, shares at Sep. 30, 2025 2,705,327 50,000 830,606            
Shares issued to pay debt, shares     3,000,296            
Exercise of Series B warrants, shares     2,324,510            
Net income               (19,649,099)  
Balance at Mar. 31, 2026 $ 2,841 $ 50 $ 10,078 151,331,793 (119,046,840) (148,291) 2,559,604 34,709,235  
Balance, shares at Mar. 31, 2026 2,840,919 50,000 10,078,089            
Balance at Dec. 31, 2025 $ 2,841 $ 50 $ 8,601 147,309,421 (119,953,888) (148,291) 1,871,855 29,090,589  
Balance, shares at Dec. 31, 2025 2,840,919 50,000 8,600,552            
Foreign currency translation loss             687,749 687,749  
Exercise of Series B warrants     $ 8 23,841       23,849  
Exercise of Series B warrants, shares     8,030            
Shares issued in offering     $ 1,469 3,998,531       4,000,000  
Shares issued in offering, shares     1,469,507            
Net income     907,048   907,048  
Balance at Mar. 31, 2026 $ 2,841 $ 50 $ 10,078 $ 151,331,793 $ (119,046,840) $ (148,291) $ 2,559,604 $ 34,709,235  
Balance, shares at Mar. 31, 2026 2,840,919 50,000 10,078,089